This early-stage study tests a single dose of a new long-acting antibody in 20 people with HIV who are not on regular medication. The goal is to see if the antibody is safe and can lower the amount of virus in the blood. Results will help design future studies for both HIV treatm…
Phase: PHASE1 • Sponsor: David Ho • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC